CLEARWATER, Fla. -- After stating in early 2002 that it would consolidate several production sites to achieve production efficiencies and rationalize its manufacturing capabilities, Maxxim Medical, Inc. has now made the last announcement in this long-term effort with the phasing out of its Richmond, Va. facility and the transitioning of production of custom procedure trays from that location to its Clearwater headquarters plant on June 13, 2003.
"During the past 18 months, Maxxim Medical has made significant strides in productivity improvement and process enhancements; advances that will now allow us to consolidate several of our production sites," says Thomas R. Cochill, president and CEO. "Process improvements and automated assembly upgrades to the Clearwater facility have made this move possible as well as beneficial. We obviously regret the impact this will have on our valued employees and our longstanding relationships within the Richmond business community."
The company does not anticipate this will affect the level of service and delivery provided to customers, noting that capacity is available in the Clearwater plant not only to absorb the Richmond production volume, but also to support anticipated future growth.
Cochill adds that this process of asset rationalization is not related to the company's recent filing for Chapter 11 reorganization. "This plan long predates our filing and reflects normal, sound business planning as part of our ongoing business management and improvement processes," he says.
Maxxim Medical is a major diversified manufacturer, assembler and marketer of specialty medical and surgical products including custom and standard procedure trays, single use drapes and gowns, medical and surgical gloves, vascular access and critical care products. Selling primarily to acute care hospitals, surgery centers and alternate care facilities, Maxxim has five plants in the United States and one in the Dominican Republic.
Source: Maxxim Medical, Inc.
Obituary: In Memory of SMART4TB and Project ACCELERATE
March 14th 2025In this remembrance of SMART4TB and Project ACCLERATE, 2 global health initiatives, Heather Stoltzfus, MPH, RN, CIC, explains what they are and why they serve as a warning of what has been lost and what more could be lost in the future.
The Art of Wise Leadership in Infection Control and Quality Management
March 14th 2025Discover how wise leadership in infection control transforms challenges into opportunities, fosters teamwork, and safeguards patient safety through emotional intelligence, strategic vision, and inspiring action.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.